Pharmaceutical Recognition of Abacavir Sulfate Sulfate, Abarelix, and Abiraterone Acetate
These substances, Abacavir Sulfate, Abarelix, and Abiraterone Acetate, each possess unique chemical architectures leading to their varying pharmacological effects. Abacavir Sulfate, a nucleoside reverse transcriptase ACEFYLLINE PIPERAZINE 18833-13-1 inhibitor, is readily detected via its molecular formula – C14H15N6O4·H2SO4 – and characteristic spectral properties observed in techniques such as mass spectrometry and infrared assessment. Abarelix, a gonadotropin-releasing hormone (GnRH) receptor antagonist, presents with a complex peptide sequence, typically requiring amino acid sequencing and peptide mapping for complete identification. Finally, Abiraterone Acetate, a CYP17 inhibitor utilized in prostate tumor treatment, can be verified through its particular mass and fragmentation patterns acquired through gas chromatography-mass spectrometry (GC-MS) alongside nuclear magnetic resonance (NMR) analytical data, ensuring its accurate chemical characterization.
Directory: Abacavir Sulfate (CAS 188062-50-2) & Related Substances
Explore the extensive product detailing Abacavir Disulfate Sulfate, identified by CAS number 188062-50-2, and a selection of associated materials. The offering includes various qualities to satisfy specific research and creation needs. Discover detailed specs including analytical data and existing packaging options. Additionally, examine our array of structurally cognate materials that may be beneficial in a current initiative. This catalog is structured to facilitate efficient acquiring of pure chemical materials.
Drug Index: Abarelex and Abirateronum Acetate Registry Codes
For researchers and medicinal professionals seeking precise drug identification, correct Chemical Abstract Service numbers are essential. Specifically, abarelix, a gonadotropin-releasing-releasing hormone modulator used in addressing prostate cancer, is designated the Registry identifier 65572-21-8. Furthermore, abiraterone acetate, a key medication in advanced disease, carries the Registry number 389292-17-3. Meticulous notation and validation of these CAS codes are imperative to ensure accurate compound assessment and following processes. Such numbers are widely available through various scientific databases. Regularly consult authorized references for the current data.
Drug Ingredients: Abacavir Sulfate Sulfate, , Abiraterone Acetate , CAS Numbers
The determination of critical pharmaceutical ingredients often relies on precise chemical designations. In particular, this piece briefly covers three significant cases: Abacavir Sodium, a drug reverse transcriptase inhibitor; Abarelix, a hormone agonist; and Abiraterone, utilized in malignant management. These compound is associated with a unique Registry number, supplying a universal method for locating details and ensuring accurate communication within the research field. Consult the respective databases for detailed records and associated records.
CAS Number Database: Information for Abacavir Sulfate, Abarelix, Abiraterone Acetate
The vast Chemical Abstracts Service (CAS) database is an essential resource for chemists and industry professionals alike. This piece quickly details records pertaining to three key medicinal compounds: Abacavir Sulfate, a nucleoside reverse transcriptase inhibitor used to combat HIV; Abarelix Acetate, a antagonist used in prostate cancer; and Abiraterone Acetate Salt, a potent drug used in the management of metastatic prostate cancer. Finding the specific CAS identification for each compound allows for certain identification and promotes precise scientific retrieval. These unique identifiers are indispensable for compound integrity and uniform communication across the industry.
Utilizing API Material Data: Compound Determination with Chemical Abstracts Service Numbers
Accurate product recognition is critical in the chemical industry, and API chemical data provides a consistent method. In particular, CAS Registry numbers act as distinct identifiers for material entities, permitting seamless integration with repositories and platforms. Such methodology not only enhances data accuracy but also streamlines workflows related to investigation, acquisition, and legal submission. Moreover, accessing this information via an API facilitates automation and lessens the risk for operator oversight.